YDO1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Madrigal Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 458.7 EUR 1.48% Market Closed

Market Cap: €9.8B

M	Madrigal Pharmaceuticals Inc F:YDO1	US
A	ANTA Sports Products Ltd XBER:AS7	CN
R	Relx PLC SWB:RDED	UK
E	Eaton Corporation PLC XMUN:3EC	IE
	American Water Works Company Inc NYSE:AWK	US
K	Kinross Gold Corp XMUN:KIN2	CA
	Heineken Holding NV AEX:HEIO	NL
	China Coal Energy Co Ltd OTC:CCOZF	CN
	Triputra Agro Persada Tbk PT IDX:TAPG	ID
B	Basf Se XHAM:BAS	DE
H	Herbalife Ltd XMUN:HOO	KY
S	Sunstone Hotel Investors Inc SWB:UF2	US
M	McCormick & Company Inc F:MCX	US
	Smith & Nephew PLC F:NPW1	UK

Profitability Summary

Madrigal Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

95%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-613%

Negative Net Margin

-27%

Negative 3Y Average Net Margin

-587%

Negative Free Cash Flow Margin

-24%

Negative 3Y Average Free Cash Flow Margin

-524%

Negative ROE

-49%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

412%

Declining ROIC

3 305% > -136%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.